April 2007
|
 |
| Diabetes and Lipid Disorders |
|
|
|
|
 |
Reduction of inflammatory biomarkers through the use of hyperlipidemia drugs in patients with diabetes |
| |
by Heidi T. May, MSPH1 • Joseph B. Muhlestein, MD1,2 |
| |
From the 1Cardiovascular Department, LDS Hospital, and 2Cardiology Division, University of Utah, Salt Lake City, Utah. |
|
|
| |
Case Report |
|
Combination therapy for mixed dyslipidemia in an elderly man with diabetes |
|
|
| |
Commentary |
|
Reducing inflammatory biomarkers: What does it mean? |
| |
by Sanjay Kaul, MD, MPH |
|
|
|
|
| Arrhythmias |
|
|
|
|
|
Preventing atrial fibrillation recurrence |
| |
by Yuehui Yin, MD1 • Darshan Dalal, MD, MPH2 • Yunqing Chen, PhD1 • Zengchang Liu, MD1 • Jinjin Wu, MD1 • Dong Liu, MD1 • Xianbin Lan, MD1 • Yin Dai , MD1 • Li Su, PhD1 • Zhiyu Ling, MD1 • Qiang She, PhD1 • Kailiang Luo, PhD1 • Kamsang Woo, MD3 • Jun Dong MD, PhD2 |
| |
From the 1Department of Cardiology, the Second Affiliated Hospital of Chongqing University of Medical Sciences, Chongqing, China; the 2Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, The Johns Hopkins Hospital/Carnegie 592, Baltimore, Maryland; and the 3Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China. |
|
|
| |
Case Report |
|
Treatment options for atrial fibrillation in a 62-year-old man |
|
|
| |
Commentary |
|
Novel approaches to rhythm control in atrial fibrillation: the role of inhibition of the renin-angiotensin system |
| |
by Eric J. Rashba, MD |
|
|
|
|
|
|
|
|
|
| Imaging |
|
|
|
|
|
Chest pain syndrome in women: a diagnostic dilemma |
| |
by Josh C. Leonard, MD; John R. Hoyle, MD; Killian Robinson, MD; and William Ntim, MD |
| |
From Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina. |
|
|
|
|
| Diabetes |
|
|
|
|
|
Effect of medication nonadherence in diabetes mellitus |
| |
by P. Michael Ho, MD, PhD1,2 • John S. Rumsfeld, MD, PhD1,2 • Frederick A.
Masoudi, MD, MSPH2,3,4 • David L. McClure, PhD, MSc5 • Mary E.
Plomondon, PhD, MSPH1 • John F. Steiner, MD2,4 • David J. Magid, MD, MPH2,5 |
| |
From the 1Denver VA Medical Center, Denver; 2University of Colorado Health Sciences Center, Denver; 3Denver Health Medical Center, Denver; 4Colorado Health Outcomes Program, University of Colorado Health Sciences Center, Denver; 5Clinical Research Unit, Kaiser Permanente of Colorado, Aurora, Colorado. |
|
|
| |
Case Report |
|
A case of disease progression or nonadherence? |
|
|
| |
Commentary |
|
Medication adherence and meaningful clinical markers in diabetes mellitus |
| |
by Kathleen L. Wyne, MD, PhD |
|
|
|
| Departments |
|
|
|
|
|
 |
|
Search
Resources
